Dr. Jordi Rodon Ahnert
Claim this profileThe University of Texas MD Anderson Cancer Center
Expert in Solid Tumors
Expert in Cancer
22 reported clinical trials
31 drugs studied
About Jordi Rodon Ahnert
Education:
- Earned an MD from the Universidad de Barcelona Faculty of Medicine in 2000.
Experience:
- Licensed to practice medicine in Texas, Florida, and Oklahoma.
- Affiliated with the University of Texas MD Anderson Cancer Center in Houston, Texas.
- Actively involved in clinical trials, including a notable Phase 1 trial for advanced solid tumors since October 2020.
- Has contributed to peer-reviewed journals, including the Journal of Clinical Oncology and Scientific Reports.
Area of expertise
1Solid Tumors
Global LeaderStage IV
Stage III
SETD2 positive
2Cancer
Global LeaderStage IV
Stage III
SETD2 positive
Affiliated Hospitals
Clinical Trials Jordi Rodon Ahnert is currently running
[225Ac]-FPI-2068
for Cancer
This is a first-in-human, Phase 1, non-randomized, multicenter, open-label clinical study designed to investigate the safety, tolerability, dosimetry, biodistribution, and pharmacokinetics (PK) of \[225Ac\]-FPI-2068, \[111In\]-FPI-2107, and FPI-2053 in metastatic and/or recurrent solid tumors (HNSCC, NSCLC, mCRC, PDAC).
Recruiting1 award Phase 16 criteria
NXP900
for Advanced Cancers
This trial is testing a new drug called NXP900 to see how safe it is for people with advanced cancers. Researchers are trying different doses to find out which one works best without causing too many side effects. The goal is to determine the best dose for future studies.
Recruiting1 award Phase 1
More about Jordi Rodon Ahnert
Clinical Trial Related1 year of experience running clinical trials · Led 22 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Jordi Rodon Ahnert has experience with
- Nivolumab
- Pembrolizumab
- Sym021
- Sym022
- Sym023
- Olaparib
Breakdown of trials Jordi Rodon Ahnert has run
Brain Cancer
Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jordi Rodon Ahnert specialize in?
Jordi Rodon Ahnert focuses on Solid Tumors and Cancer. In particular, much of their work with Solid Tumors has involved Stage IV patients, or patients who are Stage III.
Is Jordi Rodon Ahnert currently recruiting for clinical trials?
Yes, Jordi Rodon Ahnert is currently recruiting for 9 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Jordi Rodon Ahnert has studied deeply?
Yes, Jordi Rodon Ahnert has studied treatments such as Nivolumab, Pembrolizumab, Sym021.
What is the best way to schedule an appointment with Jordi Rodon Ahnert?
Apply for one of the trials that Jordi Rodon Ahnert is conducting.
What is the office address of Jordi Rodon Ahnert?
The office of Jordi Rodon Ahnert is located at: The University of Texas MD Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the The University of Texas MD Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.